An old Vertex drug gets new life as an Alzheimer's treatment, but human studies still far off
If you give a mouse a targeted enzyme inhibitor, will its cognitive decline slow down?
That’s what researchers from McGill University and the Lady Davis …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
